Iridex CorpIRIX

NasdaqHealthcareElectromedical & Electrotherapeutic Apparatus
Price (close)
$0.63
Market cap
$11.1M
P/E
—
Revenue (TTM)
$51.6M
Net income
-$3.5M
Dividend yield
—
1-year total return
-43.2%
Net margin
-6.9%
Revenue growth
3.7%
Debt / equity
—

What Iridex Corp does.

No business description on file yet.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue$36.3M$53.9M$57.0M$51.9M$48.7M$52.7M
Net income-$6.3M-$5.2M-$7.5M-$9.6M-$8.9M-$4.4M
Free cash flow-$3.3M$8.0M-$9.8M-$6.9M-$7.3M-$2.3M

More on IRIX.

Figures from Iridex Corp's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.